Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate stays one of the most crucial tools in modern anaesthesia and sharp pain management throughout the United Kingdom. As a powerful synthetic opioid, its role in the National Health Service (NHS) and personal surgical sectors is reputable, mostly due to its fast start of action and cardiovascular stability. This article supplies a detailed summary of fentanyl citrate injection solutions offered in the UK, their medical indicators, regulatory landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. read more was very first synthesized in 1960 and rapidly became a cornerstone of perioperative care. In regards to effectiveness, fentanyl is around 50 to 100 times more potent than morphine. Its high lipophilicity enables it to cross the blood-brain barrier quickly, resulting in a nearly instant analgesic impact when administered intravenously.
In the UK, fentanyl citrate is predominantly used via the parenteral path (injection) for both sedative and analgesic functions. It works mainly by binding to the mu-opioid receptors in the central worried system, altering the understanding of pain and the emotional response to it.
Scientific Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is indicated for numerous particular scientific circumstances:
- Analgesic Action: Used throughout brief personnel treatments and in the recovery room.
- Analgesic Supplement: Used throughout the induction and upkeep of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in mix with a neuroleptic (such as droperidol) to achieve a state of quiescence and reduced awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of general anaesthesia.
Offered Formulations and Strengths in the UK
The UK market uses several solutions of fentanyl citrate, designed to fulfill the varying requirements of surgical and emergency situation departments. These are usually presented as clear, colourless options for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Manufacturer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the basic concentration, specialised formulas for epidural or intrathecal use might in some cases be prepared by health center pharmacies under specific procedures.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is important for safe administration.
- Onset of Action: When administered intravenously, the effect begins almost instantly, though the optimum analgesic result might take 3 to 5 minutes.
- Duration: A single intravenous dose of 100 micrograms normally lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is primarily metabolised in the liver through the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mostly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and generally performed by anaesthetists or trained professionals in regulated environments.
Dose Guidelines
Dose needs to be horizontal and individualised based on the patient's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for small surgical procedures.
- Moderate Dose (2-- 20 mcg/kg): Used when surgical treatment is more intrusive; needs breathing monitoring.
- High Dose (20-- 50 mcg/kg): Used throughout "hassle-free" significant surgical treatments (e.g., open-heart surgery) to protect the myocardium from the metabolic needs of tension.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less typical, but utilized for pre-medication in particular scenarios.
Regulative Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked controlled drug cupboard.
- Record Keeping: Every administration should be recorded in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl should be denatured and seen by authorised personnel.
Negative Effects and Adverse Reactions
While highly effective, fentanyl citrate brings a threat of considerable adverse effects.
- Breathing Depression: The most major side effect, which can lead to respiratory arrest if not kept an eye on.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation tough, requiring the use of neuromuscular blocking representatives.
- Queasiness and Vomiting: Common in the postoperative duration.
- Hypotension: Although more steady than morphine, it can still happen, particularly in hypovolaemic patients.
Contrast with Other Opioids
Clinicians frequently pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Feature | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Minimal | Substantial | Negligible |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Often Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl spots?
No. While they include the very same active drug, the injection is for instant, intense usage in surgical or emergency settings. Patches (transdermal shipment) are created for persistent, long-term pain management and launch the medication gradually over 72 hours.
2. Can fentanyl citrate be utilized for children in the UK?
Yes, it is frequently used in paediatric anaesthesia. Nevertheless, the dose needs to be strictly computed based on the child's weight, and they need to be monitored closely for breathing anxiety.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological antagonist used to reverse the impacts of fentanyl, consisting of respiratory depression. In UK hospitals, naloxone should always be readily available anywhere fentanyl is administered.
4. Why is it used over morphine in heart surgery?
Fentanyl is preferred in heart surgery since it does not trigger the release of histamine, which can result in vasodilation and hypotension. It provides cardiovascular stability even at high dosages.
5. What are the storage requirements?
Fentanyl citrate injection must be stored below 25 ° C and protected from light. As a Schedule 2 drug, it should be kept in a legally compliant CD cabinet.
Fentanyl citrate injection solutions are indispensable components of the UK's medical toolkit for handling perioperative discomfort and facilitating intricate surgical treatments. Its high effectiveness and rapid onset deal unequaled accuracy for anaesthetists, provided that rigorous tracking and regulative standards are preserved. By understanding the numerous concentrations and the stringent procedures surrounding its usage, healthcare professionals make sure that this powerful medication stays both safe and effective for patients throughout the country.
Disclaimer: This post is for educational purposes only and does not constitute medical guidance. Healthcare specialists need to always refer to the Summary of Product Characteristics (SmPC) and existing BNF guidelines for the most current recommending information.
